arbekacin has been researched along with Infective Endocarditis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Miyake, N; Nagasaki, Y; Shimono, N; To, K | 1 |
1 other study(ies) available for arbekacin and Infective Endocarditis
| Article | Year |
|---|---|
Successful combination therapy with vancomycin and arbekacin against infective endocarditis caused by MRSA.
Topics: Adult; Anti-Bacterial Agents; Dibekacin; Drug Monitoring; Drug Therapy, Combination; Endocarditis; Female; Humans; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2011 |